BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The European School of Multimodality Imaging &amp; Therapy (ESMIT) - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The European School of Multimodality Imaging &amp; Therapy (ESMIT)
X-ORIGINAL-URL:https://esmit.eanm.org
X-WR-CALDESC:Events for The European School of Multimodality Imaging &amp; Therapy (ESMIT)
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Vienna
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260220T133000
DTEND;TZID=Europe/Vienna:20260220T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20260217T091153Z
UID:2843-1771594200-1771597800@esmit.eanm.org
SUMMARY:Beyond Single Modality: The Future of Cancer Staging with Hybrid Scanners
DESCRIPTION:This webinar will be on the future of cancer staging with hybrid imaging technologies. Participants will gain an overview of advanced PET/CT\, SPECT/CT\, and PET/MRI systems\, learning how hybrid imaging enhances diagnostic accuracy and supports more precise clinical decisions.The session will explore the practical challenges technologists face when working with these cutting-edge systems\, including image acquisition\, processing\, and interpretation\, while highlighting the technical skills needed for effective operation.We’ll also discuss educational gaps and training opportunities for radiographers and technologists\, presenting strategies such as hands-on workshops\, e-learning\, and mentorship to support professional development.By the end of this webinar\, attendees will have a clear understanding of the evolving role of technologists in hybrid oncological imaging and be inspired to embrace innovation\, lifelong learning\, and interdisciplinary collaboration. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nDescribe the most advanced hybrid imaging technologies used for oncological staging in nuclear medicine Understand the key features of PET/CT\, SPECT/CT\, and PET/MRI systems\n\n\n\nDistinguish the main advantages and limitations of hybrid modalities in clinical oncology\n\n\n\nUnderstand the added value of multimodality imaging compared with single-modality approaches Identify cases where hybrid imaging improves sensitivity\, specificity\, or diagnostic accuracy Recognize how functional-anatomical integration supports more precise clinical decisions\n\n\n\nAnalyze the main challenges faced by technologists in the acquisition\, processing\, and interpretation of hybrid imaging data Highlight practical issues (e.g.\, image registration\, calibration\, artifacts\, acquisition timing)Reflect on the technical skills required to operate hybrid systems effectively\n\n\n\nIdentify educational gaps and learning challenges encountered by radiographers/technologists when adopting new hybrid technologies Recognize organizational\, infrastructural\, and educational barriers (e.g.\, equipment availability\, supervision\, time constraints) Assess variations in training opportunities across European contexts\n\n\n\nPropose strategies and training programs for integrating hybrid skills into radiotherapy technician (RTM) programs\, fostering critical awareness of the evolving role of the technician in the context of hybrid oncology imaging.Suggest training models (advanced courses\, internships at centers of excellence\, e-learning\, hands-on workshops)Outline a roadmap for continuous development (on-the-job training\, certifications\, mentorships)\n\n\n\nPromote a proactive mindset toward technological innovation and self-development\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear medicine Technologists\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nOliver RamsaySpeaker \n\n\n\n\n\nNia HopsonSpeaker \n\n\n\n\n\nPaolo TurcoModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/beyond-single-modality-the-future-of-cancer-staging-with-hybrid-scanners/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260313T133000
DTEND;TZID=Europe/Vienna:20260313T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20260302T091708Z
UID:2845-1773408600-1773412200@esmit.eanm.org
SUMMARY:Radiobiological Aspects of PRRT
DESCRIPTION:This webinar will examine the fundamental differences between targeted radionuclide therapy (TRT) and conventional external beam radiotherapy (EBRT)\, integrating physical\, dosimetric\, and radiobiological perspectives relevant to clinical practice. Drawing on the EANM–ESTRO joint session\, the first part will outline how TRT’s systemic administration\, patient-specific pharmacokinetics\, protracted low dose-rate delivery\, and highly heterogeneous intratumoral distribution distinguish it from the controlled\, high dose-rate\, fractionated paradigm of EBRT. Emphasis will be placed on implications for treatment planning\, activity prescription\, imaging-based dosimetry\, and the limitations of directly translating EBRT concepts such as uniform dose coverage and standard fractionation models to TRT. \n\n\n\nThe second part will focus on how absorbed dose\, dose rate\, and spatial heterogeneity influence biological effectiveness and clinical outcomes in TRT. Key topics include sublethal damage repair during continuous irradiation\, challenges in applying conventional radiobiological models\, the impact of microscopic dose non-uniformity (especially for β- versus α-emitting therapies)\, and the relationship between local tumor control and systemic effects\, including immune modulation. The session aims to equip nuclear medicine physicians and medical physicists with a conceptual framework to interpret dosimetry results\, personalize treatments\, and critically evaluate emerging combination strategies as TRT evolves toward a quantitatively driven radiotherapy modality. \n\n\n\n \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nDifferentiate the fundamental physical and clinical characteristics of TRT versus EBRT\, including source geometry\, temporal delivery\, dose-rate profiles\, and implications for treatment planning and prescription.\n\n\n\nExplain how pharmacokinetics and biodistribution govern absorbed dose in TRT\, and why activity administration alone is an insufficient surrogate for delivered dose and therapeutic effect.\n\n\n\nAssess the impact of dose rate and protracted irradiation on radiobiological response\, including sublethal damage repair\, limitations of conventional linear-quadratic modeling\, and consequences for tumor control and normal tissue toxicity.\n\n\n\nRecognize the clinical significance of spatial dose heterogeneity at organ\, tumor\, and cellular scales\, particularly differences between β-emitting and α-emitting radiopharmaceutical therapies.\n\n\n\nInterpret the relationship between dosimetry metrics and clinical outcomes\, including local control\, toxicity\, and potential systemic (immune-mediated) effects.\n\n\n\nApply these concepts to support patient-specific dosimetry\, treatment personalization\, and multidisciplinary decision-making in modern targeted radionuclide therapy practice.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nThis webinar is intended for nuclear medicine physicians and medical physicists involved in targeted radionuclide therapy\, including early-career professionals and practitioners seeking to deepen their understanding of the physical and radiobiological principles underpinning modern TRT practice.\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nDavid Sánchez-ArtuñedoSpeaker \n\n\n\n\n\nZachary MorrisSpeaker \n\n\n\n\n\nSamantha TerryModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/radiobiological-aspects-of-prrt/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260327T133000
DTEND;TZID=Europe/Vienna:20260327T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20260320T084326Z
UID:2847-1774618200-1774621800@esmit.eanm.org
SUMMARY:FDG PET/CT in Inflammation and Infection: from Theory to Clinical Practice!
DESCRIPTION:Imaging of infection and inflammation has been part of nuclear medicine since the 1970s. Over the past two decades\, the growing role of FDG PET/CT in diagnosing and monitoring the treatment of a wide variety of infectious and inflammatory diseases has been recognised. As a result\, this technique has recently been adopted in several clinical guidelines. This webinar provides clinical case-based evidence to assist nuclear medicine physicians in recommending\, performing and interpreting FDG PET/CT examinations in patients with infectious and inflammatory disorders. \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nThe aim of this live webinar is to describe\, using illustrative clinical cases\, the role of FDG PET/CT in a variety of pathological conditions characterised by infection or inflammation\, with particular emphasis on strengths and limitations of FDG PET/CT.\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear Medicine Physicians\, Residents\, Technologists\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nAyah NawwarSpeaker \n\n\n\n\n\nDomenico AlbanoSpeaker \n\n\n\n\n\nSøren HessSpeaker \n\n\n\n\n\nLucia LeccisottiModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/fdg-pet-ct-in-inflammation-and-infection-from-theory-to-clinical-practice/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260410T133000
DTEND;TZID=Europe/Vienna:20260410T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20260410T073326Z
UID:2849-1775827800-1775831400@esmit.eanm.org
SUMMARY:Open your Heart on SPECT and PET Studies: Synergistic Information from the CT
DESCRIPTION:This webinar will cover synergetic information derived from the CT component in SPECT/CT and PET/CT examinations:  the first part we will focus on cardiac calcifications\, offering valuable insights into their detection and clinical relevance especially for myocardial perfusion scans. In the second half\, we will discuss incidental findings in the thorax\, helping clinicians recognize and interpret unexpected observations in SPECT/CT and PET/CT studies.  \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\nThis webinar aims to equip attendees with practical knowledge that enhances diagnostic confidence\, facilitates interdisciplinary collaboration\, and improves patient outcomes in hybrid nuclear cardiology examination. Participants will gain a deeper understanding of: \n\n\n\n \n\n\n\n\nCardiac Calcifications with CT: Learn how to identify and assess cardiac calcifications using CT imaging\, recognize their clinical significance\, and understand their implications for cardiovascular disease risk stratification in PET/CT and SPECT/CT myocardial perfusion examinations\n\n\n\nIncidental Findings in the Thorax: Develop the ability to systematically evaluate incidental thoracic findings encountered in SPECT/CT and PET/CT studies\, differentiate between benign and pathological abnormalities\, and enhance decision-making for further clinical assessment.”info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nNuclear Medicine physicians\, Cardiologists with focus on cardiovascular imaging\, Radiologists\, Technologists\, Residents in Nuclear Medicine.\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nManar BadarnahSpeaker \n\n\n\n\n\nChristoph RyffelSpeaker \n\n\n\n\n\nFederico CaobelliModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/open-your-heart-on-spect-and-pet-studies-synergistic-information-from-the-ct/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260508T133000
DTEND;TZID=Europe/Vienna:20260508T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T090823Z
UID:2851-1778247000-1778250600@esmit.eanm.org
SUMMARY:Dosimetry in Clinical Trials
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/dosimetry-in-clinical-trials/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260529T133000
DTEND;TZID=Europe/Vienna:20260529T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T090948Z
UID:2854-1780061400-1780065000@esmit.eanm.org
SUMMARY:FAP and Stroma Imaging – Current and Future Applications
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/fap-and-stroma-imaging-current-and-future-applications/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260619T133000
DTEND;TZID=Europe/Vienna:20260619T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20251111T123803Z
UID:2856-1781875800-1781879400@esmit.eanm.org
SUMMARY:Navigating International Guidelines for the Management of Thyroid Cancer
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/navigating-international-guidelines-for-the-management-of-thyroid-cancer/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260703T133000
DTEND;TZID=Europe/Vienna:20260703T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T091236Z
UID:2859-1783085400-1783089000@esmit.eanm.org
SUMMARY:Auger Electron Emitters – Why Consider this Therapeutic Option?
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/auger-electron-emitters-why-consider-this-therapeutic-option/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20260918T133000
DTEND;TZID=Europe/Vienna:20260918T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T091347Z
UID:2861-1789738200-1789741800@esmit.eanm.org
SUMMARY:Trustworthy AI and Human Oversight
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/trustworthy-ai-and-human-oversight/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261106T133000
DTEND;TZID=Europe/Vienna:20261106T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T091508Z
UID:2863-1793971800-1793975400@esmit.eanm.org
SUMMARY:With a Little Help of Artificial Intelligence for the Sake of Radiation Protection
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/with-a-little-help-of-artificial-intelligence-for-the-sake-of-radiation-protection/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261127T133000
DTEND;TZID=Europe/Vienna:20261127T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20251111T123905Z
UID:2865-1795786200-1795789800@esmit.eanm.org
SUMMARY:Ring Geometry SPECT/CT System
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/ring-geometry-spect-ct-system/
CATEGORIES:Live Webinars
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Vienna:20261211T133000
DTEND;TZID=Europe/Vienna:20261211T143000
DTSTAMP:20260422T022118
CREATED:20251004T070000Z
LAST-MODIFIED:20251001T091729Z
UID:2867-1796995800-1796999400@esmit.eanm.org
SUMMARY:Tips and Tricks on Imaging with New CZT SPECT Systems
DESCRIPTION:More info will come soon \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nRegister nowEnrol in the live webinar now for free! Register now\n\n\n\n\n\n\n\n \n\n\n\n \n\n\n\nLearning Objectives\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nTarget Audience\n\n\n\n \n\n\n\n\nMore info will come soon\n\n\n\n\n \n\n\n\n \n\n\n\nFaculty\n\n\n\n \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerSpeaker \n\n\n\n\n\nSpeakerModerator \n\n\n\n\n\n\n\n\n\nEvent Overview
URL:https://esmit.eanm.org/event/tips-and-tricks-on-imaging-with-new-czt-spect-systems/
CATEGORIES:Live Webinars
END:VEVENT
END:VCALENDAR